Recently, there is preliminary in vivo evidence that circulating Nrg4 levels were significantly decreased in newly diagnosed type 2 diabetes mellitus (nT2DM) patients with DPN [3], however, the pathological mechanism underlying the relationship between decreased plasma Nrg4 levels and increased risk of DPN remains poorly understood. Here, NRG4 is linked to diabetes mellitus.